Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Gullino LS"'
The atypical protein tyrosine phosphatase enzyme, dual-specificity phosphate 15 (DUSP15) is thought to be activated by myelin regulatory factor (MyRF) and to have a role in oligodendrocyte differentiation. Here, we assess whether Dusp15 is reduced in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51522f3cff695b5690100e958d13eacb
https://ora.ox.ac.uk/objects/uuid:b7832473-581e-4a35-a31e-a26fe5033af5
https://ora.ox.ac.uk/objects/uuid:b7832473-581e-4a35-a31e-a26fe5033af5
Autor:
Collins HM; Dept. of Pharmacology, University of Oxford, Oxford, UK.; Dept. of Experimental Psychology, University of Oxford, Oxford, UK., Gullino LS; Dept. of Pharmacology, University of Oxford, Oxford, UK., Ozdemir D; Dept. of Pharmacology, University of Oxford, Oxford, UK., Lazarenco C; Dept. of Pharmacology, University of Oxford, Oxford, UK., Sudarikova Y; Dept. of Pharmacology, University of Oxford, Oxford, UK., Daly E; Dept. of Pharmacology, University of Oxford, Oxford, UK., Pilar Cuéllar F; Dept. of Pharmacology, University of Oxford, Oxford, UK.; Departamento de Señalización Molecular y Celular, Instituto de Biomedicina y Biotecnología de Cantabria (IBBTEC), Departamento de Fisiología y Farmacología, Facultad de Medicina, Universidad de Cantabria, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Santander, Spain., Pinacho R; Dept. of Experimental Psychology, University of Oxford, Oxford, UK., Bannerman DM; Dept. of Experimental Psychology, University of Oxford, Oxford, UK., Sharp T; Dept. of Pharmacology, University of Oxford, Oxford, UK. trevor.sharp@pharm.ox.ac.uk.
Publikováno v:
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology [Neuropsychopharmacology] 2024 Sep; Vol. 49 (10), pp. 1580-1589. Date of Electronic Publication: 2024 Apr 12.
Autor:
Gullino LS; University Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT, U.K., Fuller C; University Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT, U.K., Dunn P; University Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT, U.K., Collins HM; University Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT, U.K., El Mestikawy S; Douglas Mental Health University Institute, Department of Psychiatry, McGill University, Montreal, QC H4H 1R3, Canada.; Sorbonne Université, INSERM, CNRS, Neuroscience Paris Seine - Institut de Biologie Paris Seine (NPS - IBPS), 75005 Paris, France., Sharp T; University Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT, U.K.
Publikováno v:
ACS chemical neuroscience [ACS Chem Neurosci] 2024 Mar 20; Vol. 15 (6), pp. 1185-1196. Date of Electronic Publication: 2024 Feb 20.
Autor:
Rawlings-Mortimer F; Wellcome Centre for Integrative Neuroimaging, Nuffield Dept of Clinical Neurosciences, Oxford, United Kingdom., Gullino LS; Department of Pharmacology, University of Oxford, Oxford, United Kingdom., Rühling S; Department of Neuroradiology, School of Medicine, Technical University of Munich, Munich, Germany., Ashton A; Nuffield Department of Clinical Neurosciences, Sleep and Circadian Neuroscience Institute, University of Oxford, Oxford, United Kingdom., Barkus C; Department of Experimental Psychology, University of Oxford, Oxford, United Kingdom., Johansen-Berg H; Wellcome Centre for Integrative Neuroimaging, Nuffield Dept of Clinical Neurosciences, Oxford, United Kingdom.
Publikováno v:
PloS one [PLoS One] 2023 Feb 02; Vol. 18 (2), pp. e0281264. Date of Electronic Publication: 2023 Feb 02 (Print Publication: 2023).